This is a StreetInsider.com Premium Only Page

Advaxis (ADXS) – Guidance

Jun 27, 2019 06:53 AM Advaxis (ADXS) Announces Increasing Focus on Neoantigen-Directed Immunotherapies, Reports Closing of Its Phase 3 AIM2CERV Study

Jun 7, 2018 09:08 AM Advaxis (ADXS) Reports Elimination of About 24% of Company’s Workforce as Part of Restructuring

Mar 12, 2018 04:09 PM

Oct 13, 2016 08:10 AM

Jan 8, 2016 07:08 AM

Jun 25, 2015 07:32 AM

Jan 12, 2015 07:37 AM